Adaptation to blockade of human immunodeficiency virus type 1 entry imposed by the anti-CCR5 monoclonal antibody 2D7

Virology

Volumn 287, Issue 2, 2001, Pages 382-390

  Aarons, Emma J ^a   Beddows, Simon ^b   Willingham, Tim ^a   Wu, Lijun ^c   Koup, Richard A ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c MILLENNIUM PHARMACEUTICALS INC   (United States)

Author keywords

CCR5; Coreceptor; gp120; HIV 1; Monoclonal antibody

Indexed keywords

CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; GLYCOPROTEIN GP 120; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 2D7; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN;

ADAPTATION; ANTIBODY RESPONSE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG TARGETING; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IC 50; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; VIRUS ADSORPTION; VIRUS ISOLATION; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0035450601     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2001.1046     Document Type: Article

References (59)

1. CC-chemokine receptor 5 genotypes and in vitro susceptibility to HIV-1 of a cohort of British HIV exposed-uninfected homosexuals
2. Rapid development of isolate-specific neutralizing antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous sera
3. CC CKR5: A RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1
4. Multiple extracellular elements of CCR5 and HIV-1 entry: Dissociation from response to chemokines
5. Homozygous D 32 deletion of the CCR-5 chemokine receptor gene in an HIV-1-infected patient
6. HIV-1-induced cell fusion is mediated by multiple regions within both the viral envelope and the CCR-5 co-receptor
7. HIV-1 infection in an individual homozygous for the CCR5 deletion allele
8. Maternal HIV-1 viral load and vertical transmission of infection: The Ariel Project for the prevention of HIV transmission from mother to infant
9. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates
10. In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors
11. Characterization of the functional properties of env genes from long-term survivors of human immunodeficiency virus type 1 infection
12. CC chemokine receptor 5 cell-surface expression in relation to CC chemokine receptor 5 genotype and the clinical course of HIV-1 infection
13. Association between CCR5 genotype and the clinical course of HIV-1 infection
14. The molecular target of bicyclams, potent inhibitors of human immunodeficiency virus replication
15. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study
16. Identification of a major co-receptor for primary isolates of HIV-1
17. A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors
18. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5
19. Amino-terminal substitutions in the CCR5 coreceptor impair gp120 binding and human immunodeficiency virus type 1 entry
20. Shift of clinical human immunodeficiency virus type 1 isolates from X4 to R5 and prevention of emergence of the syncytium-inducing phenotype by blockade of CXCR4
21. A tyrosine-rich region in the N terminus of CCR5 is important for human immunodeficiency virus type 1 entry and mediates an association between gp120 and CCR5
22. In vitro selection of variants of human immunodeficiency virus type 1 resistant to 3′-azido-3′-deoxythymidine and 2′,3′-dideoxyinosine
23. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS
24. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression
25. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody
26. Epitope mapping of CCR5 reveals multiple conformational states and distinct but overlapping structures involved in chemokine and coreceptor function
27. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection
28. Distribution of the CCR5 gene 32-bp deletion in Europe
29. Involvement of both the V2 and V3 regions of the CCR5-tropic human immunodeficiency virus type 1 envelope in reduced sensitivity to macrophage inflammatory protein 1alpha
30. Global distribution of the CCR5 gene 32-basepair deletion
31. Generation of neutralization-resistant HIV-1 in vitro due to amino acid interchanges of third hypervariable env region
32. Resistance of a human serum-selected human immunodeficiency virus type 1 escape mutant to neutralization by CD4 binding site monoclonal antibodies is conferred by a single amino acid change in gp120
33. Characterization of HIV-1 neutralization escape mutants
34. Human immunodeficiency virus type 1 mutants that escape neutralization by human monoclonal antibody IgG1b12
35. Sensitive ELISA for the gp120 and gp160 glycoproteins of HIV-1
36. Dissociation of gp120 from HIV-1 virions induced by soluble CD4
37. Highly potent RANTES analogues either prevent CCR5-using human immunodeficiency virus type 1 infection in vivo or rapidly select for CXCR4-using variants
38. Phenotypic expressions of CCR5-delta32/delta32 homozygosity
39. HIV-1 infection in a man homozygous for CCR5 Δ32
40. Macrophage-tropic and T-cell line-adapted chimeric strains of human immunodeficiency virus type 1 differ in their susceptibilities to neutralization by soluble CD4 at different temperatures
41. Restriction of HIV type 1 infection in macrophages heterozygous for a deletion in the CC-chemokine receptor 5 gene
42. Reduced HIV-1 infectability of CD4+ lymphocytes from exposed-uninfected individuals: Association with low expression of CCR5 and high production of beta-chemokines
43. Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposure
44. Multiple extracellular domains of CCR-5 contribute to human immunodeficiency virus type 1 entry and fusion
45. Chemokine receptor CCR5 genotype influences the kinetics of human immunodeficiency virus type 1 infection in human PBL-SCID mice
46. Generation of a neutralization-resistant variant of HIV-1 is due to selection for a point mutation in the envelope gene
47. A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding
48. Regions in b-chemokine receptors CCR5 and CCR2b that determine HIV-1 cofactor specificity
49. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene
50. T-cell-line-tropic human immunodeficiency virus type 1 that is made resistant to stromal cell-derived factor 1 alpha contains mutations in the envelope gp120 but does not show a switch in coreceptor use
51. Genotypic and phenotypic characterization of a neutralization-resistant breakthrough population of HIV-1
52. Selective employment of chemokine receptors as human immunodeficiency virus type 1 co-receptors determined by individual amino acids within the envelope V3 loop
53. HIV-1 infection in an individual homozygous for CCR5 Δ32
54. Interaction of chemokine receptor CCR5 with its ligands: Multiple domains for HIV-1 gp120 binding and a single domain for chemokine binding
55. CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro
56. Mutations of the HIV type 1 V3 loop under selection pressure with neutralizing monoclonal antibody NM-01
57. Characterization of mutants of human immunodeficiency virus type 1 that have escaped neutralization by a monoclonal antibody to the gp120 V2 loop
58. Genetic characteristics of vif, vpr, and vpu sequences from long-term survivors of human immunodeficiency virus type 1 infection
59. HIV-1 subtype and second-receptor use